Yuming Feng - Arctic Bioscience Exec Devel

ABS Stock  NOK 2.06  0.04  1.98%   

Insider

Yuming Feng is Exec Devel of Arctic Bioscience AS
Age 60
Phone47 95 29 33 84
Webhttps://www.arctic-bioscience.com

Arctic Bioscience Management Efficiency

The company has return on total asset (ROA) of (0.1149) % which means that it has lost $0.1149 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2215) %, meaning that it generated substantial loss on money invested by shareholders. Arctic Bioscience's management efficiency ratios could be used to measure how well Arctic Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Patricia KellyPhotocure
N/A
Flemming AndersenNapatech AS
N/A
Terje PilskogScatec Solar OL
52
Dirk HahneiserArcticzymes Technologies ASA
55
Pal WibeXXL ASA
55
Jethro HolterArcticzymes Technologies ASA
51
Tom PreststulenElkem ASA
76
Kjetil RamstadSolstad Offsho
N/A
Jacob GregersenCadeler As
N/A
Zygimantas DirseKitron ASA
43
Stine TryggHaugerXXL ASA
41
Jon GummedalSolstad Offsho
N/A
Darren EllisArcticzymes Technologies ASA
N/A
Magnus LindsethKitron ASA
46
Hans ThomassenKitron ASA
58
Torstein BerntsenScatec Solar OL
53
Kenneth LandeSolstad Offsho
N/A
Kristoffer AsklovKitron ASA
46
Henrik JensenNapatech AS
N/A
Pal StromScatec Solar OL
47
Meera BhatiaScatec Solar OL
N/A
Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products. Arctic Bioscience AS was incorporated in 2011 and is based in rsta, Norway. ARCTIC BIOSCIENCE is traded on Oslo Stock Exchange in Norway. Arctic Bioscience AS (ABS) is traded on Oslo Stock Exchange in Norway and employs 13 people.

Management Performance

Arctic Bioscience Leadership Team

Elected by the shareholders, the Arctic Bioscience's board of directors comprises two types of representatives: Arctic Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arctic. The board's role is to monitor Arctic Bioscience's management team and ensure that shareholders' interests are well served. Arctic Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arctic Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steffen Eidal, VP Marketing
Runhild Gammelster, Global Director
Christer Valderhaug, Chief Officer
Yuming Feng, Exec Devel
Hogne Hallaraker, Founder Officer
Jone Slinning, Chief Officer
MBA MSc, CoFounder Chairman
Daniele Mancinelli, Chief Officer
Alvin Berger, Chief Officer
Per Sbo, Chief Officer

Arctic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Arctic Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Arctic Stock

Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.